Christopher Smith, MD
Internal Medicine · Ft. Thomas, KYNPI 1205837069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $778 and has fallen 94.5% since, to $43 in 2024.
Across 88 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$152
- Ironshore Pharmaceuticals Inc.$144
- Johnson & Johnson$132
- Neotract Inc.$129
- Merck$119
- Pfizer$71
- plus $448 from 19 others
Across 3 payments — averaging $36,041 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$98K
- Roche TCRC, Inc.$10K
What the payments were for
- Food & beverage$1,195100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $152 |
| Ironshore Pharmaceuticals Inc. | 8 | $144 |
| Johnson & Johnson | 13 | $132 |
| Neotract Inc. | 1 | $129 |
| Merck | 18 | $119 |
| Pfizer | 6 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $70 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Boehringer Ingelheim | 3 | $39 |
| AstraZeneca | 3 | $33 |
| Abiomed | 1 | $27 |
| Bausch Health US, LLC | 2 | $27 |
| Novartis | 2 | $26 |
| Cranial Technologies, Inc | 1 | $25 |
| Amgen | 2 | $23 |
| Amarin Pharma, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Sobi, Inc | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
| GSK | 1 | $11 |
| Dynavax Technologies Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$129
How this compares
$1,195 in reported general payments places this provider in the 65th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Ft. Thomas
- Fares KhaterWhitesburg$412K
- Bernard BuchananOwensboro$185K
- David ManninoLexington$168K
- John PeppinCynthiana$108K
- Sanjay KaulBrownsville$69K
- John JonesHazard$63K
- Robert SasserLouisville$62K
- Justin LandeDanville$60K
- Sanjiv GuptaGrayson$49K
- Kelley McIntyreLouisville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.